drugset / Trial / NCT03016494

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

NCT03016494 ↗

Phase 1 Unknown 56 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the safety and pharmacokinetics between co-administration and fixed dose combination of DWC20155 and DWC20156 in healthy subjects

Timeline

Start
2016-02
Primary completion
2017-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — —
Subject DWC20156 Unknown — —
Subject DWJ1386 Unknown — —

Indications

No indication recorded.